These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 23999211)
1. Haematological cancer: rituximab maintenance improves the outcome of elderly patients with FL. Jones B Nat Rev Clin Oncol; 2013 Nov; 10(11):607. PubMed ID: 23999211 [No Abstract] [Full Text] [Related]
2. The annual meeting of the American Society of Clinical Oncology. June 4-8, 2010; Chicago, IL. CIG Media Group Clin Lymphoma Myeloma Leuk; 2010 Oct; 10(5):323-30. PubMed ID: 21030344 [No Abstract] [Full Text] [Related]
3. Hematology: Rituximab for follicular lymphoma: maintaining an open mind. Cheson BD Nat Rev Clin Oncol; 2011 May; 8(5):257-8. PubMed ID: 21403667 [No Abstract] [Full Text] [Related]
4. Rituximab maintenance versus radioimmunotherapy consolidation in follicular lymphoma: which, when, and for whom? Forstpointner R; Dreyling M Curr Hematol Malig Rep; 2011 Dec; 6(4):207-15. PubMed ID: 21909660 [TBL] [Abstract][Full Text] [Related]
5. Maintenance rituximab should be considered for patients with follicular lymphoma. Barr PM Clin Adv Hematol Oncol; 2014 Aug; 12(8):541-3. PubMed ID: 25356579 [No Abstract] [Full Text] [Related]
6. Optimization of postremission therapy in follicular lymphoma: efficacy of rituximab maintenance. Roy R; Gordon LI J Natl Compr Canc Netw; 2011 May; 9(5):563-71. PubMed ID: 21550969 [TBL] [Abstract][Full Text] [Related]
8. Rituximab as first-line maintenance therapy following rituximab-containing therapy for follicular lymphoma: profile report. Croxtall JD BioDrugs; 2011 Oct; 25(5):329-31. PubMed ID: 21942917 [No Abstract] [Full Text] [Related]
9. Maintenance rituximab in follicular non-Hodgkin lymphoma: facts and controversies. Nabhan C; Smith SM; Kahl BS Leuk Lymphoma; 2012 May; 53(5):770-8. PubMed ID: 21958083 [TBL] [Abstract][Full Text] [Related]
10. [Cost-effectiveness analysis of maintenance therapy with rituximab in patients with follicular lymphoma responding to induction therapy at the first line]. Castro Gómez AJ; López-Guillermo A; Rueda Domínguez A; Salar A; Varela Moreno C; Rubio-Terrés C Rev Esp Salud Publica; 2012; 86(2):163-76. PubMed ID: 22991059 [TBL] [Abstract][Full Text] [Related]
11. Rituximab maintenance obviates the poor prognosis associated with circulating lymphoma cells in patients with follicular lymphoma. Sarkozy C; Seymour JF; Ferme C; Caballero D; Ghesquieres H; Leppa S; Delarue R; Pedersen LM; Mounier C; Gomes Da Silva M; Chassagne-Clement C; Maerevoet M; Salles G Blood; 2014 Apr; 123(17):2740-2. PubMed ID: 24764560 [No Abstract] [Full Text] [Related]
12. Rituximab use and survival after diffuse large B-cell or follicular lymphoma: a population-based study. Keegan TH; Moy LM; Foran JM; Alizadeh AA; Chang ET; Shema SJ; Schupp CW; Clarke CA; Glaser SL Leuk Lymphoma; 2013 Apr; 54(4):743-51. PubMed ID: 22957852 [TBL] [Abstract][Full Text] [Related]
13. Rituximab maintenance improves overall survival of patients with follicular lymphoma-Individual patient data meta-analysis. Vidal L; Gafter-Gvili A; Salles G; Bousseta S; Oberman B; Rubin C; van Oers MH; Fortpied C; Ghielmini M; Pettengell R; Witzens-Harig M; Dreger P; Vitolo U; Gomes da Silva M; Evangelista A; Li H; Freedman L; Habermann TM; Shpilberg O Eur J Cancer; 2017 May; 76():216-225. PubMed ID: 28336303 [TBL] [Abstract][Full Text] [Related]
14. Peripheral blood lymphocyte/monocyte ratio predicts outcome in follicular lymphoma and in diffuse large B-cell lymphoma patients in the rituximab era. Belotti A; Doni E; Bolis S; Rossini F; Casaroli I; Pezzatti S; Pogliani EM; Pioltelli PE Clin Lymphoma Myeloma Leuk; 2015 Apr; 15(4):208-13. PubMed ID: 25468321 [TBL] [Abstract][Full Text] [Related]
15. Follicular lymphoma in Sweden: nationwide improved survival in the rituximab era, particularly in elderly women: a Swedish Lymphoma Registry study. Junlén HR; Peterson S; Kimby E; Lockmer S; Lindén O; Nilsson-Ehle H; Erlanson M; Hagberg H; Rådlund A; Hagberg O; Wahlin BE Leukemia; 2015 Mar; 29(3):668-76. PubMed ID: 25151959 [TBL] [Abstract][Full Text] [Related]
16. Rituximab maintenance for the treatment of patients with follicular lymphoma: an updated systematic review and meta-analysis of randomized trials. Vidal L; Gafter-Gvili A; Salles G; Dreyling MH; Ghielmini M; Hsu Schmitz SF; Pettengell R; Witzens-Harig M; Shpilberg O J Natl Cancer Inst; 2011 Dec; 103(23):1799-806. PubMed ID: 22021664 [TBL] [Abstract][Full Text] [Related]
17. Usefulness of second rituximab maintenance after relapse in patients with follicular and mantle cell lymphoma. Sanchez-Gonzalez B; Gimeno E; Garcia-Pallarols F; Ancochea A; Salar A Leuk Lymphoma; 2014 Oct; 55(10):2384-6. PubMed ID: 24601815 [No Abstract] [Full Text] [Related]
18. Has the time to come leave the "watch-and-wait" strategy in newly diagnosed asymptomatic follicular lymphoma patients? Rueda A; Casanova M; Redondo M; Pérez-Ruiz E; Medina-Pérez A BMC Cancer; 2012 May; 12():210. PubMed ID: 22650448 [TBL] [Abstract][Full Text] [Related]
19. Clinical outcome of patients with follicular lymphoma receiving chemoimmunotherapy in the PRIMA study is not affected by FCGR3A and FCGR2A polymorphisms. Ghesquières H; Cartron G; Seymour JF; Delfau-Larue MH; Offner F; Soubeyran P; Perrot A; Brice P; Bouabdallah R; Sonet A; Dupuis J; Casasnovas O; Catalano JV; Delmer A; Jardin F; Verney A; Dartigues P; Salles G Blood; 2012 Sep; 120(13):2650-7. PubMed ID: 22885164 [TBL] [Abstract][Full Text] [Related]